EACTS Membership
Learn more APPLY NOW

INDUSTRY OPPORTUNITIES

The EACTS Annual Meeting is the largest event for the cardiothoracic community, attracting several thousand delegates. It provides the perfect forum to promote your products and services to the world’s leading cardiothoracic surgeons as well as physicians in related specialties, residents and allied health professionals. 

 

In addition to our large Exhibition we will be offering a range of other sponsorship opportunities to our Industry partners participating in at the 2023 Annual Meeting in Vienna.  Further details will be shared soon – if you would like to be included in receiving these, please contact industry@eacts.co.uk.

SATELLITE SYMPOSIA

The following companies will be organising satellite symposia during the 36th Annual Meeting. These sponsored programmes do not form part of the official scientific programme of EACTS. By attending these sessions, please be aware that you will be giving permission for your personal details to be shared with the company holding the symposium.

 

Thursday 6th October, 12:45-14:00

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 5

Website

Innovative strategies for superior outcome in Cardiac Surgery including pMCS support in therapy pathway

Chairs: Professor Hermann Reichenspurner (Hamburg, Germany), Professor Roberto Lorusso (Maastricht, Germany)

Prevention of PCCS in high-risk Cardiac Surgery patients by elective implant of pMCS
Dr. Assad Haneya (Kiel, Germany)

Structural heart disease – innovative approaches extending therapy scope by using pMCS support
Dr. Bastian Schmack (Essen, Germany)

Tailored solutions to treat advanced CGS patients combining ECMO with pMCS
Professor Evgenij Potapov (Berlin, Germany) 

Date: Thursday 6 October
Time: 12:45-14:00
Room: Botticelli
Contact: Jane Bettoni – Jane.Bettoni@artivion.com

Website

Beyond the hemiarch: a simple therapy for Acute Type A Dissections

Moderators: Professor Benussi (Brescia, Italy), Professor Oo (London, UK)

3-Year Outcomes of the Dissected Aorta Repair Through Stent Implantation Trial
Dr M. Moon (Edmonton, Canada)

The arch remodelling stent for DeBakey 1 AAD: experience with 100 implantations
Dr M. Montagner (Berlin, Germany)

Early results of a novel hybrid prosthesis for treatment of AATAD with distal anastomosis beyond zone 0
Prof P. Akhyari (Achen, Germany)

How to introduce a new therapeutic approach in the acute setting
Mr R. De Silva (Cambridge, UK)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 4
Contact: salessupportEU@atricure.com

Website

A patient-centric approach for AF treatment

Chairs: Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada), Carlo De Asmundis M.D., Ph.D, Universitair Ziekenhuis (Brussels, Belgium)

Who should be treated in 2022?
Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada)

Meet-my-patients roundtable (patient cases presentations)
– Concomitant Surgical Ablation + LAA: Mark La Meir M.D., Ph.D., Universitair Ziekenhuis (Brussels, Belgium)
Hybrid case + LAA: Thorsten Hanke MD., Ph.D., Asklepios Klinikum Harburg (Hamburg, Germany)
– LAA management: Stefano Branzoli M.D., Ospedale S. Chiara (Trento, Italy)

Closing remarks: there is a solution for all AF patients
Richard Whitlock M.D., Ph.D., McMaster University (Hamilton, Canada)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 1 & 2
Contact: Anne Chafii-Jaguello, Infection Prevention Marketing Manager (EMEA) – Anne.Chafii-Jaguello@bd.com

Website

Surgical Site Infections in cardiac surgery: optimizing prevention measures

Chair: Professor Menicanti

Speakers: Prof Petrosillo & Mr Lucchese

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 3
Contact: Sonia Hennou (Dir, Professional Ed and Medical Affairs) Sonia_Hennou@edwards.com; Florian Novat (Manager, Professional Education and Medical Affairs) Florian_Novat@edwards.com

Website

State of the art in the treatment of aortic valve regurgitation in young patients

Chairs: Torsten Doenst, Ruggero De Paulis

When there is a disconnect between guidelines and patient wishes, the importance of individualized care
Torsten Doenst

Aortic regurgitation: the importance of early referral and anatomical assessment
Ruggero De Paulis

Management of aortic regurgitation: gaps, current evidences and future options
Thomas Senage

Assessment of a new bioprosthetic valve to treat young patients with bicuspid aortic valve
Siamak Mohammadi

Panel Discussion

Date: Thursday 6 October
Time: 12:45-14:00
Room: Amber 3
Contact: Carolin Thiery – c.thiery@koehler-chemie.de

Website

Mission (Im)Possible – Four Cornerstones for Success in Cardiac Surgery

Chairs: Friedhelm Beyersdorf (Freiburg), Jochen Cremer (Kiel)

Personalized Indication – why not a complex surgical procedure in a frail octogenarian?
Milan Milojevic (Rotterdam)

Importance of Surgical Technique – Consequences of imperfect surgical results beyond the direct injury
Jolanda Kluin (Amsterdam)

Organ Protection & Cardioplegic Solutions – Do we have the fi nal insight into the problem?
Serdar Gunaydin (Ankara)

Perioperative Cellular Protection – “Failure to prepare is preparing to fail”
Friedhelm Beyersdorf (Freiburg)

Date: Thursday 6 October
Time: 12:45-14:00
Room: Michelangelo

Website

Cardiac Surgery time machine: Get ready for the future!

Chairs: Prof. Pieter Kappetein, Prof. Joerg Kempfert

Welcome on board
Prof. Kempfert, Prof. Kappetein 

The acceleration of clinical knowledge. Real world data or still controlled studies?
Prof. Meuris

TAVI are now used in patients of all surgical risks. Are you on board?
Prof. Modine

Lifetime management and patient longevity, what is the best patient scenario?
Prof. Borger

Do we still perform sternotomy, or it is now all MICS?
Prof. Pitsis 

When there is equality, we all thrive! Removing the barriers to diversity and inclusion in Cardiac Surgery.
Dr. Rashmi Yadav

Final discussion and closure
Prof. Kappetein, Prof. Kempfert

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 1
Contact: Anne Waaler – anne.waaler@medistim.com

Website

Routine Quality Assessment in CABG and Aortic surgery

Moderator: Professor John Puskas (New York)

Expert recommendations for TTFM use
Mario Gaudino (New York)

CABG cases – How to interpret TTFM
David Glineur (Ottawa)

Aortic cases – Why is epiaortic ultrasound guidance important?
Konstantinos Tsagakis (Essen)

TTFM and HFUS in  CABG – interactive case discussion
John Puskas (New York) & David Taggart (Oxford)

Q&A

Date: Thursday 6 October
Time: 12:45-14:00
Room: Brown 2
Contact: info@resuscitec.de

Website

CARL. Controlled Automated Reperfusion of the whoLe body – A new concept treating patients with cardiac arrest

Chairs: Frederico Pappalardo (Alessandria), José Luis Pomar (Barcelona)

Scientific background to CARL Therapy – The new kid in town
Jan-Steffen Pooth (Freiburg)

Implementation of CARL – Never walk alone
Hug Aubin (Düsseldorf )

Preparation for CARL Therapy – Just Do It
Christoph Benk (Freiburg)

Shifting the limits of resuscitation – Latest multicenter clinical results
Georg Trummer (Freiburg)

Round Table Discussion

Thursday 6th October, 18:00-19:15

Date: Thursday 6 October
Time: 18:00-19:15
Room: Amber 4
Contact: Elad Harf – elad.harf@graftsolutions.com

Website

Bright future for vein grafts: techniques and technologies to improve the clinical outcome of CABG

Preclinical evidence of the biomechanical effects of external vein graft support
Prof. Peter Zila

The bio mechanical effect of external support and applications
Prof. David P Taggart

Randomized controlled data of VEST external stent
Prof. Nikolaos Bonaros

Improved clinical outcome of CABG with external stent – real world evidence
Prof. Luca P Weltert

Friday 7th October, 12:45-14:00

Date: Friday 7 October
Time: 12:45-14:00
Room: Brown 2
Contact: infoEMEA@abbott.com

Website

From Established to Advanced Heart Failure Therapies and Technologies that Change Lives

Chairs: Mariano Feccia (Italy) & Francesco Maisano (Italy) 

Welcome and Introduction
Mariano Feccia (Italy) & Francesco Maisano (Italy)

Surgical Mitral Valve Repair vs Replacement in the Modern Era of Transcatheter Valve Interventions
Joerg Kempfert (Germany)

When can Tendyne™ TMVR be a relevant substitute for on-pump MVR
Rüdiger Lange (Germany)

HeartMate 3™ LVAD positioning and implications for patient outcomes
Dominik Wiedemann (Austria)

5-year survival with LVAD Therapy in MOMENTUM 3
Sern Lim (United Kingdom)

Round table discussion and closing

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 3
Contact: Jane Bettoni – Jane.Bettoni@artivion.com

Website

Choosing the most appropriate treatment option for arch pathologies

Moderators: Professor Shrestha (Rochester, USA), Professor Grabenwöger (Vienna, Austria)

Transition from Evita Open Plus to Evita Open NEO – The West German Heart Center (Essen) Experience
Dr K. Tsagakis (Essen, Germany)

Evita Open NEO in acute aortic dissections
Dr D. Dohle (Mainz, Germany)

Decision algorithm for DeBakey type 1 AAD
Mr R. De Silva (Cambridge, UK)

Endovascular aortic arch repair with Nexus: technical insights and 3-year outcomes
Prof. A. D’Onofrio (Padova, Italy)

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 4
Contact: Kristin von Hammerstein – Kristin.vonHammerstein@cytosorbents.com

Website

Hemoadsorption with CytoSorb in high-risk cardiac surgery indications – new data

Chair: Guillaume Lebreton (Paris, France), Piotr Suwalski (Warsaw, Poland)

Removal of antithrombotic drugs to reduce bleeding complications and costs in high urgency operations
Michael Schmoeckel (Hamburg, Germany)

Clinical benefits in patients undergoing heart transplantation – results of a single center RCT
Endre Németh (Budapest, Hungary)

CytoSorb in infective endocarditis patients – what can we learn from recent data?
Matthias Thielmann (Essen, Germany)

Date: Friday 7 October
Time: 12:45-14:00
Room: Brown 3
Contact: Sonia Hennou (Dir, Professional Ed and Medical Affairs) Sonia_Hennou@edwards.com; Florian Novat (Manager, Professional Education and Medical Affairs) Florian_Novat@edwards.com

Website

Aortic valve disease: Patient centric management in elderly population

Chairs: Marjan Jahangiri, Vinod Thourani 

Management of aortic valve diseases: what do the guidelines indicate for patients over the age of 65?
Matthias Siepe

Not all biological valves are equal: a single-center experience
Amedeo Anselmi

Burden of degenerated TAVI: which therapeutic approach?
Vinod Thourani

Enhanced Recovery After Cardiac Surgery in elderly population: benefits of a multi-modal approach
Jan Gummert

Panel Discussion

Date: Friday 7 October
Time: 12:45-14:00
Room: Michelangelo

Website

Top secrets you need to know for your success in SAVR

Chairs: Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Welcome on board
Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Revealing Avalus top secret. Let us discover what makes it unique!
Dr. De Raet (Belgium )

Avalus hemodynamics at its best! 
Dr. Hwang (Korea)

Avalus real world evidence: first results of 300+ patients!  
Prof. Verbelen (Belgium)

Avalus in younger patients (< 65). Real world experience and clinical evidence.
Dr. Greco (UK)

When size matters, choose Avalus! Largest internal diameter and opening reserve.
Mr. Pousios (UK)

Final discussion and closure
Prof. Reichenspurner (Germany), Prof. Günther Laufer (Austria)

Date: Friday 7 October
Time: 12:45-14:00
Room: Amber 1 & 2
Contact: Lindsay McMaster- l.mcmaster@terumoaortic.com

Website

Thoraflex Hybrid: Gold Standard

Moderator: Professor Roberto Di Bartolomeo

Normotheric approach with FET
Professor Marco De Eusanio

Clinical Data supporting the Gold Standard
Professor Davide Pacini

A new Era for FET in the US
Professor Joseph Coselli

Hybrid technology addressing Thoracoabdominal Challenges
Professor Sabine Wipper

Saturday 8th October

The European Board of Cardiovascular Perfusion

Date: Saturday 8 October
Room: Raphael

Website

EBCP Annual Meeting / 22nd EcOPEaT / Milan 08/10/2022

 

EcOPEaT Symposium Details

The 36th EACTS Annual Meeting has been registered as COMPLIANT by MedTech.

Exhibitor List 2022

The EACTS trade exhibition is an important and most time efficient way to keep up to date with new to market technology, state of the art products, innovations and developments in the cardiothoracic market.  The exhibiting companies are looking forward to meet the people that matter to their business in one place, demonstrate new products and attract interest from new prospects and existing customers.

The support of our industry partners is important. As we develop more flexible and innovative ways to communicate and share educational content, we are excited to offer new engagement opportunities for our industry partners.

We look forward to working with you.  For full details and pricing, please contact industry@eacts.co.uk